cross chemist limited
cross chemist limited Company Information
Company Number
09002720
Next Accounts
Jun 2025
Shareholders
dash healthcare ltd
rupa rayani
View AllGroup Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
5 royal parade, london, W5 1ET
Website
crosschemist.co.ukcross chemist limited Estimated Valuation
Pomanda estimates the enterprise value of CROSS CHEMIST LIMITED at £316.7k based on a Turnover of £958.9k and 0.33x industry multiple (adjusted for size and gross margin).
cross chemist limited Estimated Valuation
Pomanda estimates the enterprise value of CROSS CHEMIST LIMITED at £104.7k based on an EBITDA of £27.7k and a 3.78x industry multiple (adjusted for size and gross margin).
cross chemist limited Estimated Valuation
Pomanda estimates the enterprise value of CROSS CHEMIST LIMITED at £0 based on Net Assets of £-158.9k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cross Chemist Limited Overview
Cross Chemist Limited is a live company located in london, W5 1ET with a Companies House number of 09002720. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in April 2014, it's largest shareholder is dash healthcare ltd with a 66.7% stake. Cross Chemist Limited is a established, small sized company, Pomanda has estimated its turnover at £958.9k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cross Chemist Limited Health Check
Pomanda's financial health check has awarded Cross Chemist Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
7 Weak
Size
annual sales of £958.9k, make it smaller than the average company (£12.3m)
- Cross Chemist Limited
£12.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (7.5%)
- Cross Chemist Limited
7.5% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Cross Chemist Limited
32.4% - Industry AVG
Profitability
an operating margin of -5.9% make it less profitable than the average company (2.9%)
- Cross Chemist Limited
2.9% - Industry AVG
Employees
with 9 employees, this is below the industry average (74)
9 - Cross Chemist Limited
74 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
- Cross Chemist Limited
£25.8k - Industry AVG
Efficiency
resulting in sales per employee of £106.5k, this is less efficient (£144.8k)
- Cross Chemist Limited
£144.8k - Industry AVG
Debtor Days
it gets paid by customers after 39 days, this is later than average (30 days)
- Cross Chemist Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 63 days, this is close to average (64 days)
- Cross Chemist Limited
64 days - Industry AVG
Stock Days
it holds stock equivalent to 34 days, this is in line with average (36 days)
- Cross Chemist Limited
36 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (14 weeks)
6 weeks - Cross Chemist Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 143.1%, this is a higher level of debt than the average (58.6%)
143.1% - Cross Chemist Limited
58.6% - Industry AVG
CROSS CHEMIST LIMITED financials
Cross Chemist Limited's latest turnover from September 2023 is estimated at £958.9 thousand and the company has net assets of -£158.9 thousand. According to their latest financial statements, Cross Chemist Limited has 9 employees and maintains cash reserves of £62.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 9 | 11 | 8 | 6 | 7 | 7 | 7 | 7 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 70 | 333 | 767 | 3,253 | 7,067 | 10,262 | 5,400 | 3,277 | |
| Intangible Assets | 84,674 | 169,348 | 254,022 | 338,696 | 423,370 | 508,044 | 592,718 | 677,392 | 762,066 |
| Investments & Other | 1 | 1 | 1 | ||||||
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | 84,674 | 169,419 | 254,356 | 339,464 | 426,623 | 515,111 | 602,980 | 682,792 | 765,343 |
| Stock & work in progress | 61,946 | 58,000 | 52,888 | 67,500 | 62,903 | 70,500 | 55,483 | 45,000 | 39,142 |
| Trade Debtors | 105,026 | 108,537 | 195,001 | 49,285 | 55,484 | 52,045 | 7,980 | 7,980 | 93,439 |
| Group Debtors | |||||||||
| Misc Debtors | 54,747 | 69,815 | 33,510 | 71,275 | 65,475 | 49,668 | 125,799 | 134,264 | |
| Cash | 62,222 | 137,234 | 66,984 | 47,530 | 12,549 | 9,033 | 54,648 | 56,780 | 32,175 |
| misc current assets | 1 | 1 | |||||||
| total current assets | 283,941 | 373,586 | 348,383 | 235,590 | 196,412 | 181,247 | 243,911 | 244,024 | 164,756 |
| total assets | 368,615 | 543,005 | 602,739 | 575,054 | 623,035 | 696,358 | 846,891 | 926,816 | 930,099 |
| Bank overdraft | 50,701 | 54,150 | 50,000 | ||||||
| Bank loan | |||||||||
| Trade Creditors | 112,252 | 118,937 | 98,349 | 94,959 | 83,297 | 75,335 | 82,826 | 99,512 | 512,390 |
| Group/Directors Accounts | 245,089 | 245,089 | 245,089 | ||||||
| other short term finances | |||||||||
| hp & lease commitments | |||||||||
| other current liabilities | 170,176 | 169,841 | 144,756 | 144,882 | 458,833 | 466,260 | 480,650 | 460,896 | |
| total current liabilities | 527,517 | 584,568 | 542,344 | 289,841 | 542,130 | 541,595 | 563,476 | 560,408 | 512,390 |
| loans | 59,321 | 107,060 | 211,145 | 258,881 | 304,719 | 352,125 | 394,152 | ||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | 245,089 | 440,685 | |||||||
| provisions | |||||||||
| total long term liabilities | 59,321 | 107,060 | 456,234 | 258,881 | 304,719 | 352,125 | 394,152 | 440,685 | |
| total liabilities | 527,517 | 643,889 | 649,404 | 746,075 | 801,011 | 846,314 | 915,601 | 954,560 | 953,075 |
| net assets | -158,902 | -100,884 | -46,665 | -171,021 | -177,976 | -149,956 | -68,710 | -27,744 | -22,976 |
| total shareholders funds | -158,902 | -100,884 | -46,665 | -171,021 | -177,976 | -149,956 | -68,710 | -27,744 | -22,976 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 71 | 263 | 434 | 2,619 | 3,814 | 3,814 | 3,049 | 1,756 | 856 |
| Amortisation | 84,674 | 84,674 | 84,674 | 84,674 | 84,674 | 84,674 | 84,674 | 84,674 | 84,674 |
| Tax | |||||||||
| Stock | 3,946 | 5,112 | -14,612 | 4,597 | -7,597 | 15,017 | 10,483 | 5,858 | 39,142 |
| Debtors | -18,579 | -50,159 | 107,951 | -399 | 19,246 | -32,066 | -8,465 | 48,805 | 93,439 |
| Creditors | -6,685 | 20,588 | 3,390 | 11,662 | 7,962 | -7,491 | -16,686 | -412,878 | 512,390 |
| Accruals and Deferred Income | 335 | 25,085 | -126 | -313,951 | -7,427 | -14,390 | 19,754 | 460,896 | |
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | -1 | 1 | |||||||
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | 245,089 | ||||||||
| Other Short Term Loans | |||||||||
| Long term loans | -59,321 | -47,739 | -104,085 | -47,736 | -45,838 | -47,406 | -42,027 | 394,152 | |
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | -245,089 | 245,089 | -440,685 | 440,685 | |||||
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | -75,012 | 70,250 | 19,454 | 34,981 | 3,516 | -45,615 | -2,132 | 24,605 | 32,175 |
| overdraft | -50,701 | -3,449 | 4,150 | 50,000 | |||||
| change in cash | -24,311 | 73,699 | 15,304 | -15,019 | 3,516 | -45,615 | -2,132 | 24,605 | 32,175 |
cross chemist limited Credit Report and Business Information
Cross Chemist Limited Competitor Analysis
Perform a competitor analysis for cross chemist limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in W 5 area or any other competitors across 12 key performance metrics.
cross chemist limited Ownership
CROSS CHEMIST LIMITED group structure
Cross Chemist Limited has no subsidiary companies.
cross chemist limited directors
Cross Chemist Limited currently has 3 directors. The longest serving directors include Mr Ashish Shah (Apr 2014) and Mr Jay Rayani (Apr 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Ashish Shah | England | 45 years | Apr 2014 | - | Director |
| Mr Jay Rayani | 44 years | Apr 2014 | - | Director | |
| Mr Dhaval Patel | United Kingdom | 46 years | Apr 2014 | - | Director |
P&L
September 2023turnover
958.9k
-10%
operating profit
-57.1k
0%
gross margin
32.5%
-3.31%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
-158.9k
+0.58%
total assets
368.6k
-0.32%
cash
62.2k
-0.55%
net assets
Total assets minus all liabilities
cross chemist limited company details
company number
09002720
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
April 2014
age
11
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
5 royal parade, london, W5 1ET
Bank
-
Legal Advisor
-
cross chemist limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to cross chemist limited. Currently there are 0 open charges and 2 have been satisfied in the past.
cross chemist limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CROSS CHEMIST LIMITED. This can take several minutes, an email will notify you when this has completed.
cross chemist limited Companies House Filings - See Documents
| date | description | view/download |
|---|
